If it triggers or the pen looks wrong on arrival, email us
In major clinical trials, GLP-1s were linked to fewer strokes, heart attacks, and other serious heart issues, even for people taking other heart medications
It influences reproductive health, bone density, and even mood regulation
They reduce the level of fat in the liver, which is associated with improved health and reduced risk of cardiac or glycemic abnormalities
Future research The clinical development of retatrutide is ongoing, with several phase 3 trials, collectively known as the TRIUMPH program, currently underway
Unlike current treatments, which often focus on a single pathway, Retatrutide's multi-pathway approach could potentially lead to more effective and sustained weight loss